T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...

Lower brain oxygen levels caused by sleep apnea were linked to changes to the white matter, which could lead to cognitive ...

ABC News' Dr. Darien Sutton breaks down the FDA’s approval of the popular weight loss medication for the treatment of ...

Dr. Nunez describes CPAP machines as the "gold standard" in the treatment of obstructive sleep apnea. "If you’ve been diagnosed with sleep apnea, your doctor may recommend that you use a CPAP ...

How to talk to your doctor about Zepbound for sleep ... Lilly's weight loss drug is becoming a more common treatment option for sleep apnea. “I can see why some physicians would offer Zepbound ...

“Of importance, if sleep apnea affects the brain health and increases the risk for dementias, then treatment of it can ... as the one mentioned serve as a way to understand early markers of ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...